Skip to content
Home
LIVE · CORPUS
SnitchScore · reading…
evidence coverage · reading…
Coverage — measured
Ownership hops held
1000

An absent edge means not yet observed — never does not exist.

Legal entityMedium

Contineum Therapeutics, Inc.

Contineum Therapeutics, Inc. — US company (sec:0001855175). UBO chain traced 1000 hops, 11 owners. Every claim linked to its source.

SEC 0001855175CompanyUS
Ownership graph Export .md
The finding

Ownership resolves 1000 hops deep toward the ultimate beneficial owner.

Investigative lead by resolved identity, not a legal determination.

/01

Ownership & control

Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.

Owners / controllers
Holdings / subsidiaries

None in current sources.

Walk the full UBO chain
1000 hops lockedSTANDARD

1000-step ownership / control trace to the ultimate beneficial owner — cited at every hop. Unlock the full chain.

Unlock Standard Dossier€39
Standard Dossier€39

The full ownership trace on this subject — every hop to the ultimate owner, its filing history and sanctions exposure — as PDF and JSON, every claim linked to its source.

Everything we hold on Contineum Therapeutics, Inc., resolved and sourced — yours to keep, no subscription.

INCLUDED WHEN YOU UNLOCK
  • UBO trace
  • Branded PDF + un-redacted JSON · every claim linked to its source
  • Re-download for 90 days

UBO trace

Guest checkout · email only · re-download 90 days. Or subscribe from €149.

WHAT YOU CAN SEEFREE
YOURS NOW · FREE

4 items you can read right now — no account, no payment.

  • Identity, address & registry profile
  • Sanctions & watchlist detail
  • Direct connections (1 hop)
  • Community notes
YOURS AFTER YOU UNLOCK · PAID

2 more items, hidden until you unlock this dossier. The badge on each row names the dossier that includes it.

  • Full ownership trace to the UBOSTANDARD
  • Full export (PDF + un-redacted JSON) & change alertsPREMIUM
/02

People & control

21 parties · 0 current

Every officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.

21 parties · 0 current. Ceased and resigned records are retained as history.

/03

Common questions

Who owns Contineum Therapeutics, Inc.?
In the current sources, Contineum Therapeutics, Inc. is connected to Versant Vantage I, L.P., VERSANT VENTURES IV, LLC, Versant Vantage I GP, L.P., VERSANT SIDE FUND IV, L.P., Versant Ventures VI GP, L.P. and 6 more. Trace the full chain to the ultimate beneficial owner in the WhiteIntel ownership graph.
What is Contineum Therapeutics, Inc.'s risk level?
WhiteIntel flags Contineum Therapeutics, Inc. as medium risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.
Where does Contineum Therapeutics, Inc. appear across sources?
Contineum Therapeutics, Inc. is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on Contineum Therapeutics, Inc.. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnitchScore.

Sign in to contribute a tip and earn reputation — it's free.
Loading tips…